Spironolactone with ACE inhibitor is effective in gross hematuria caused by nephroptosis

Int J Urol. 2006 Jul;13(7):990-2. doi: 10.1111/j.1442-2042.2006.01454.x.

Abstract

Gross hematuria caused by nephroptosis is difficult to treat and sometimes requires surgical treatment. We experienced a case of a 64-year-old woman with gross hematuria due to nephroptosis and glomerular thin basement membrane that showed remission of hematuria with the blockade of the renin-angiotensin-aldosterone system with an angiotensin-converting enzyme inhibitor and spironolactone.

Publication types

  • Case Reports

MeSH terms

  • Biopsy
  • Diagnosis, Differential
  • Female
  • Follow-Up Studies
  • Hematuria / diagnosis
  • Hematuria / drug therapy*
  • Hematuria / etiology
  • Humans
  • Kidney / pathology*
  • Kidney Diseases / complications*
  • Kidney Diseases / diagnosis
  • Magnetic Resonance Imaging
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Spironolactone / therapeutic use*

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone